Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Oxurion NV to Present at 2019 Biotech Showcase Conference and Participate in CEO Power Breakfast Roundtable during the 37th Annual J.P. Morgan Healthcare Conference

19 Dec 2018

Leuven, Belgium, 19 December 2018 Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases affecting the back of the eye, announced today that Patrik De Haes, M.D., chief executive officer, will present a company overview at the 2019 Biotech ShowcaseTM conference at 3:30 p.m. PST on Tuesday, Jan. 8, 2019 at the Hilton San Francisco Union Square.

Additionally, Dr. De Haes will participate in a CEO power breakfast roundtable as a panellist at 7 a.m. PST on Wednesday, Jan. 9, 2019 at the Sir Francis Drake Hotel in San Francisco. The panel will feature life sciences executives examining topics including drug innovation and strategic partnering moderated by FierceBiotech editor, Amirah Al Idrus. Please fill out the contact form to RSVP for the event.

Furthermore, Oxurion’s management team will also hold one-on-one meetings with institutional investors and analysts Jan. 7-9 in San Francisco. Institutional investors and analysts can register and request meetings through the online system.

Press release attachment: 
Tags: 
Company